Amgen has gone through a lot of trouble to ink this deal, courting not only Seattle-based Immunex but also American Home Products (nyse: AHP - news - people ), which co-markets Enbrel and has a 41% stake in Immunex.

FORBES: Amgen, Immunex: The Arthritis Merger